Abstract
dc:description.abstractThe discovery, in 1989, of the gene responsible for Cystic Fibrosis (CF), the cystic fibrosis transmembrane conductance regulator (CFTR), led to the development of mouse models of this disease. Such models were designed to facilitate the dissection of disease pathogenesis, to study the correlation between genotype and phenotype and to establish an invaluable resource for the development and evaluation of novel therapeutic agents. Fundamental to the success of such studies was the requirement that the mutant animals should develop the key phenotypic features of CF in humans. Initial characterisation of the first mouse models of CF demonstrated that they could be unequivocally distinguished from their wild type littermates and displayed many important disease features. However, the most important clinical consequence of CF, the development of chronic pulmonary infection with fibrotic lung damage, was not initially evident. In studies that preceded this thesis, we demonstrated an abnormal pulmonary phenotype in the Edinburgh CF mouse (Cftrᵗᵐ¹ᴴᵍᵘ /Cftrᵗᵐ¹ᴴᵍᵘ), on an outbred MF1 background, in response to repeated exposure to CF related respiratory pathogens. These observations established this mouse as an important model system for studies aimed at elucidating the mechanisms involved in the development of CF lung disease. The aims of this thesis were 1) to further characterise lung disease in mouse models of cystic fibrosis, and 2) to study the mechanisms underlying the development of this disease.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2000
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Davidson, Donald John
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/33496